Metraipolis › archive › dc_de7ebe738de0
Rethinking Synthetic Berberine in Nutraceuticals: Nitrosamine Risks, Regulatory Oversight, and Safer Alternatives — Europe PMC PMID:41226233
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41226233
- DOI
- 10.3390/molecules30214274
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T19:48:09.394Z
- SHA-256 of the archived text
d7d7c73135f8a604106c712ca89a702eed43e68e4368d1f83e0c7b081818186b- Stable URL of this page
https://metraipolis.com/documento/dc_de7ebe738de0
How to cite
Rethinking Synthetic Berberine in Nutraceuticals: Nitrosamine Risks, Regulatory Oversight, and Safer Alternatives — Europe PMC PMID:41226233 — Europe PMC (en), https://europepmc.org/article/MED/41226233 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_de7ebe738de0 (Metraipolis archive dc_de7ebe738de0, sha256 d7d7c73135f8a604106c712ca89a702eed43e68e4368d1f83e0c7b081818186b)
BibTeX
@misc{dcde7ebe738de0,
title = {Rethinking Synthetic Berberine in Nutraceuticals: Nitrosamine Risks, Regulatory Oversight, and Safer Alternatives — Europe PMC PMID:41226233},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41226233},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_de7ebe738de0; sha256 d7d7c73135f8a604106c712ca89a702eed43e68e4368d1f83e0c7b081818186b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41226233. Agents can read the archived copy with the MCP tool read_document.